SCHEMBL6561008

SCHEMBL6561008

CCS(=O)(=O)N(C)C1CC(C)(C)Oc2cc(N3CCCC3)c(F)cc21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNE1 P15382 7/20 0.37
KCNQ1 P51787 7/20 0.37
MAPT P10636 6/20 0.36
ALDH1A1 P00352 4/20 0.36
RAB9A P51151 3/20 0.36
HPGD P15428 3/20 0.36
NPC1 O15118 2/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
NPSR1 Q6W5P4 1/20 0.35
TSHR P16473 2/20 0.34
LMNA P02545 1/20 0.32
GAA P10253 1/20 0.32
RXFP1 Q9HBX9 1/20 0.32
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2D6 P10635 1/20 0.31
CYP2C19 P33261 1/20 0.31
KCND3 Q9UK17 1/20 0.31
POLB P06746 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6559601 0.82 MAPT (0.31) MAPTALDH1A1RAB9AHPGDNPC1
SCHEMBL6558771 0.81 KCNE1 (0.40) KCNE1KCNQ1MEN1KMT2ACYP1A2
SCHEMBL6559484 0.78 MAPT (0.36) MAPTALDH1A1RAB9AHPGDNPC1
SCHEMBL6558662 0.77 KCNE1 (0.39) KCNE1KCNQ1MEN1KMT2ACYP1A2
SCHEMBL6559271 0.77 KCNE1 (0.61) KCNE1KCNQ1MEN1KMT2ACYP1A2
SCHEMBL6559593 0.76 KCNE1 (0.38) KCNE1KCNQ1MEN1KMT2ACYP1A2
SCHEMBL6559258 0.74 KDM4E (0.37) KCNE1KCNQ1MEN1KMT2ACYP1A2
Hydrochloric Acid SCHEMBL6559571 0.74 TSHR (0.35) MAPTALDH1A1RAB9AHPGDNPC1
SCHEMBL6558707 0.73 KCNE1 (0.45) KCNE1KCNQ1MEN1KMT2ACYP1A2
SCHEMBL6561166 0.72 KCNE1 (0.44) KCNE1KCNQ1MEN1KMT2ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0807629-B1 Sulfonamido substituted chromane derivatives, method for their preparation, their use as medicaments or diagnostic agents aswell as medicaments containing them AVENTIS PHARMA GMBH (DE) 2004-03-03 EP disclosed
US-6191164-B1 POTASSIUM CHANNEL MODULATORS; ANTIULCER AGENTS HOECHST AKTIENGESELLSCHAFT (DE) 2001-02-20 US disclosed
EP-0807629-A1 Sulfonamido substituted chromane derivatives, method for their preparation, their use as medicaments or diagnostic agents aswell as medicaments containing them HOECHST AKTIENGESELLSCHAFT (DE) 1997-11-19 EP disclosed